News Search

Tag: Annual Report

Verismo launches with CAR-T expert co-founders

Verismo, a new cell therapy company pioneering multi-chain CAR-T technology, raised $16 million in equity financing. 

G2Bio launches with $200M to invest in research and development of novel gene therapies

The G2 Bio Companies, founded by James M. Wilson and the late Tachi Yamada, launched with a $200 million investment commitment from the global investment firm Temasek.

School of Veterinary Medicine faculty form a key biotech partnership

Iveric Bio entered into a sponsored research agreement with Drs. Karina Guziewicz and William Beltran both from the School of Veterinary Medicine.

Freddie Mac partners with Wharton faculty to understand regulations on housing affordability

Wharton Professor Susan Wachter is working with Freddie Mac to address the nation’s crisis of housing affordability which  is worsening over time.

AbbVie partners with Penn Chemistry and the Molander Lab

AbbVie has entered into two Sponsored Research Agreements with the lab of Gary Molander, PhD, Professor of Chemistry in the School of Arts & Sciences.

Cancer technology leads to a new startup

Awarded a patent that describes novel autophagy inhibitors potentially useful in cancer therapy.

Gene therapy pioneer invents new therapy to improve delivery of gene therapies to treat ocular diseases

Awarded a patent that describes mRNA trans-splicing as a gene therapy for treatment of ocular diseases caused by defects in large genes.

Penn Engineer invents DNA sequencing and SNP detection technology

Arjun Raj, PhD, Assistant Professor in the School of Engineering, was awarded a patent for technology that captures an innovative method to detect Single Nucelotide Polymorphisms (SNPs).

Interius Therapeutics raises record-breaking Series A round

A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million

PCI’s Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty luminaries

On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology

Filter

Skip to content